Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CITIC Pacific is a diversified conglomerate and a principal subsidiary of CITIC Limited, a leading Chinese state-owned enterprise. The company has established a significant footprint in the healthcare sector through its specialized platform, CITIC Pacific Healthcare, which focuses on hospital investment, management, and the development of elderly care services in China. Additionally, CITIC Pacific owns Dah Chong Hong (DCH), one of the largest distributors of pharmaceutical and healthcare products in Asia, providing comprehensive supply chain and market entry services to global life science companies. By integrating medical services with robust distribution capabilities, CITIC Pacific serves as a vital link in the healthcare ecosystem across Greater China and Southeast Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CITIC Pacific.